Jonathan Silverstein's Net Worth
Jonathan Silverstein's net worth is estimated to be at least $117,752,256.61 as of 04/16/2024. CoreStreet's estimation of Jonathan Silverstein's net worth is based on their sale of stock and current holding of stock.
Jonathan Silverstein is Director at Arcutis Biotherapeutics Inc. They have executed at least 8 trades of stock as per SEC Form 4 filings. Their most recent trade was for 558,888 units of ARQT stock on 02/03/2020. Their biggest sale was on 03/23/2015 when they sold 159,400 units of Intercept Pharmaceuticals Inc stock for $43,863,692.00. They typically trade 1 times per year.
Total value of insider buys:
- $19,329,898.32
Total value of insider sells:
- $98,422,358.29
Most recent insider trade:
- Feb. 3, 2020
Jonathan Silverstein's Insider Trading History
| Arcutis Biotherapeutics Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Feb. 3, 2020 | Director | 558,888 | $25.64 | Buy | $14,329,888.32 |
| Glaukos Corp | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
March 2, 2018 | Director | 464,583 | $32.29 | Sell | $15,001,385.07 |
Aug. 12, 2016 | Director | 292,938 | $33.69 | Sell | $9,869,081.22 |
| Intercept Pharmaceuticals Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
March 24, 2015 | Director | 45,600 | $272.00 | Sell | $12,403,200.00 |
March 23, 2015 | Director | 159,400 | $275.18 | Sell | $43,863,692.00 |
Aug. 25, 2014 | Director | 50,000 | $295.59 | Sell | $14,779,500.00 |
Oct. 21, 2013 | Director | 40,088 | $62.50 | Sell | $2,505,500.00 |
Oct. 16, 2012 | Director | 333,334 | $15.00 | Buy | $5,000,010.00 |